CORNING, N.Y., September 2006 - Corning Incorporated (NYSE: GLW) today announced the commercial launch of the Epic™ system, a high-throughput label-free screening platform based on optical biosensor technology. The system performs both biochemical and cell-based drug discovery applications and offers drug developers the ability to evaluate promising new drug targets. It also allows for the observation of direct biological interactions not previously detectable in high-throughput applications.
